Skip to main content

Colonoscopy the Paradigm Shift

May 14, 2024By

EndoCuff Vision® is a mechanical enhancement device used during screening colonoscopy to improve polyp and adenoma detection rates in real-world clinical settings has set a paradigm shift within colonoscopy procedures. The latest lifesaving statistics are compelling and now show that 5 million have been sold, with 49,000 colon cancers prevented and over 9,500 lives saved. Data has shown a colonoscopy with EndoCuff® technology can increase the adenoma detection rate (ADR) by up to 11% compared to a standard colonoscopy, EndoCuff® has revolutionised detection rates within cancer screening.

DesignEdge has worked intensively over a number of years to help design, develop and innovate a medical device to improve the colonoscopy procedure in terms of visibility, detection, speed and patient comfort. The key was to maximize the viewable mucosa during endoscopic therapy by manipulating the colonic folds. The unique industrial design uses advanced polymer technology to provide a rigid support structure combined with flexible projections which gently open the colon wall. EndoCuff® reduces slippage, assisting the physician by maintaining a steady view while instruments are fed through the biopsy channel. Designed to maintain and maximize the viewable mucosa during endoscopic therapy by manipulating colonic folds, a row of flexible arms evert and flatten folds to provide an enhanced view of the entire colon. The design language reflects a compact, high quality, technically detailed device suitable for a medical environment. EndoCuff® has won a number of prestigious design awards including the Industrial Product Design of the Year category of the Plastics Industry Awards 2013, dedicated to rewarding innovation and exceptional performance to the best designers within the polymer field. Also the coveted Red Dot award and a silver award in the A’ Design Awards and was a finalist in both the Design Week and D&AD Awards.

Mr Patrick Axon MD, FRCS (ORL-HNS), Arc Medical Design, “We have been working closely for a number of years to develop innovative medical products for identifying precancerous lesions in screening colonoscopy. DesignEdge has a highly experienced team dedicated to creating novel solutions to difficult problems. Their approach of combining thought provoking simple and beautiful designs that can be mass produced for a worldwide market is why we chose DesignEdge for all of our design work. Your team is everything when developing new game-changing products, always pick winners and all of our team are win-win players, without whom EndoCuff would not have seen the light of day.”

In July 2020 Olympus Corporation announced it has signed a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. The acquisition underscores Olympus’ commitment to expanding its offering in gastrointestinal therapeutic devices and the development of advanced colonoscopy tools through M&A (mergers and acquisitions) opportunities as well as through R&D (research and development) with the overarching goal of improving early detection and treatment of colorectal cancer (CRC). “It is a great pleasure to announce our acquisition of Arc Medical Design”, said Mike Callaghan, Vice President/General Manager of Global GI EndoTherapy Business Unit at Olympus. “Endocuff Vision® has been a pivotal tool in our EndoTherapy portfolio, and we are delighted to expand our product portfolio to include the entire EndoCuff® family.”

Close Menu

DesignEdge Cambridge Ltd
Unit 5 Quy Court
Cambridge CB25 9AU

Tel +44 (0)1223 566439